These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


191 related items for PubMed ID: 791182

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Platelet monamine oxidase in chronic schizophrenia. Some enzyme characteristics relevant to reduced activity.
    Murphy DL, Donnelly CH, Miller L, Wyatt RJ.
    Arch Gen Psychiatry; 1976 Nov; 33(11):1377-81. PubMed ID: 985048
    [Abstract] [Full Text] [Related]

  • 3. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders.
    Orsulak PJ, Schildkraut JJ, Schatzberg AF, Herzog JM.
    Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252
    [Abstract] [Full Text] [Related]

  • 4. Substrate-typic changes of platelet monoamine oxidase activity in sub-types of schizophrenia.
    Demisch L, von der Mühlen H, Bochnik HJ, Seiler N.
    Arch Psychiatr Nervenkr (1970); 1977 Dec 28; 224(4):319-29. PubMed ID: 606205
    [Abstract] [Full Text] [Related]

  • 5. Platelet monoamine oxidase activity in subgroups of schizophrenic disorders.
    Schildkraut JJ, Orsulak PJ, Schatzberg AF, Herzog JM.
    Schizophr Bull; 1980 Dec 28; 6(2):220-5. PubMed ID: 7375853
    [Abstract] [Full Text] [Related]

  • 6. Platelet monoamine oxidase activity in schizophrenia: a review of the data.
    Wyatt RJ, Potkin SG, Murphy DL.
    Am J Psychiatry; 1979 Apr 28; 136(4A):377-85. PubMed ID: 371419
    [Abstract] [Full Text] [Related]

  • 7. Effect of neuroleptic drugs on platelet monoamine oxidase in psychiatric patients.
    Meltzer HY, Duncavage MB, Jackman H, Arora RC, Tricou BJ, Young M.
    Am J Psychiatry; 1982 Oct 28; 139(10):1242-8. PubMed ID: 6127035
    [Abstract] [Full Text] [Related]

  • 8. Monoamine oxidase in chronic schizophrenia: Studies of hormonal and other factors affecting enzyme activity.
    Murphy DL, Belmaker R, Carpenter WT, Wyatt RJ.
    Br J Psychiatry; 1977 Feb 28; 130():151-8. PubMed ID: 319862
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Some kinetic parameters of platelet monoamine oxidase in chronic schizophrenia.
    Kobes RD, Potkin SG, Wise CD, Bridge TP, Neckers LM, Wyatt RJ.
    Psychiatry Res; 1979 Oct 28; 1(2):179-85. PubMed ID: 298347
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Delusional misidentification and platelet monoamine oxidase.
    Barton JL, Chaparala S, Barton ES, Jackson IV, Davis LG.
    Biol Psychiatry; 1980 Apr 28; 15(2):275-82. PubMed ID: 7417616
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Platelet monoamine oxidase and clinical phenomenology of schizophrenia.
    Baron M, Gruen R, Levitt M, Kane J.
    Psychiatry Res; 1984 Mar 28; 11(3):205-9. PubMed ID: 6587413
    [Abstract] [Full Text] [Related]

  • 20. Platelet monoamine oxidase activity in acute schizophrenia: relationship to symptomatology and neuroleptic medication.
    Owen F, Bourne RC, Crow TJ, Fadhli AA, Johnstone EC.
    Br J Psychiatry; 1981 Jul 28; 139():16-22. PubMed ID: 7296184
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.